|
Mechanism5-HT receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.GB |
First Approval Date15 Mar 1974 |
100 Clinical Results associated with Jinan Yongning Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Jinan Yongning Pharmaceutical Co. Ltd.
100 Deals associated with Jinan Yongning Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Jinan Yongning Pharmaceutical Co. Ltd.